(3Z,5Z)-3,5-bis(3,4,5-trimethoxybenzylidene)-tetrahydrothiopyran-4-one | 1360119-15-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (3Z,5Z)-3,5-bis(3,4,5-trimethoxybenzylidene)-tetrahydrothiopyran-4-one
• 英文别名: 3,5-bis((Z)-3,4,5-trimethoxybenzylidene)tetrahydro-4H-thiopyran-4-one；(3E,5E)-3,5-bis(3,4,5-trimethoxybenzylidene)-tetrahydrothiopyran-4-one；(3Z,5Z)-3,5-bis[(3,4,5-trimethoxyphenyl)methylidene]thian-4-one
• CAS: 1360119-15-8
• 化学式: C₂₅H₂₈O₇S
• 分子量: 472.559
• InChiKey: AKXBYDPKCCRYOP-ZEELXFFVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  33
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  97.8
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  四氢噻喃-4-酮 、 3,4,5-三甲氧基苯甲醛 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 以55 %的产率得到(3Z,5Z)-3,5-bis(3,4,5-trimethoxybenzylidene)-tetrahydrothiopyran-4-one
  参考文献：
  名称：

  BP-M345 as a Basis for the Discovery of New Diarylpentanoids with Promising Antimitotic Activity

  摘要：

  最近，人们发现二芳基戊烷类化合物 BP-M345 (5) 是一种有效的体外癌细胞生长抑制剂，其 GI50 值介于 0.17 至 0.45 µM 之间，对非肿瘤细胞的毒性较低。BP-M345 (5) 通过干扰有丝分裂纺锤体的组装，促进有丝分裂停滞，导致细胞凋亡。在之前工作的基础上，我们设计并合成了一个 BP-M345 (5) 类似物文库，并评估了该文库中三种人类癌细胞株的细胞生长抑制活性，以便进行结构-活性关系（SAR）研究，并获得具有更好抗沉降作用的化合物。有四个化合物（7、9、13 和 16）具有活性，其中化合物 7、13 和 16 的生长抑制作用与明显的有丝分裂停止有关。这些化合物的有丝分裂指数与 BP-M345 (5)相似，甚至更高，其中化合物 13 的抗有丝分裂活性最高，它干扰了有丝分裂纺锤体的动力学，导致纺锤体崩溃，从而延长了有丝分裂停滞时间，最终导致大量癌细胞凋亡。

  DOI：

  10.3390/ijms25031691

文献信息

• [EN] CURCUMIN ANALOGS AND METHODS OF USE THEREOF<br/>[FR] ANALOGUES DE LA CURCUMINE ET PROCÉDÉS D'UTILISATION
  申请人：UNIV RUTGERS

  公开号：WO2012021692A1

  公开（公告）日：2012-02-16

  Curcumin analogs and methods of use thereof are provided.

  提供了姜黄素类似物及其使用方法。
• New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity
  作者：Yali Zhang、Zhiguo Liu、Jianzhang Wu、Bin Bai、Hongjin Chen、Zhongxiang Xiao、Lingfeng Chen、Yunjie Zhao、Hazel Lum、Yi Wang、Hong Zhang、Guang Liang

  DOI：10.1016/j.ejmech.2018.02.008

  日期：2018.3

  An overactive Toll-like receptor (TLR) signaling complex is a significant pathogenic factor of acute and chronic inflammatory diseases. The natural product curcumin is reported to inhibit the TLR4 co-receptor, MD2 (myeloid differentiation protein 2), but its low in vivo bioavailability limits its therapeutic potential. We developed new curcumin analogs (MACs) with removal of the beta-diketone moiety and substituted residues in benzene rings, and identify these as potential MD2 inhibitors with improved inhibition potency and stability over that of curcumin. Specifically, MAC 17 and 28 showed the highest anti-inflammatory activity, with >90% inhibition of LPS-stimulated cytokine secretion from macrophages, and protected against LPS-induced acute lung injury and sepsis. The MACs inhibited the TLR4-MD2 signaling complex through competition with LPS for binding on MD2, likely at Arg(90). Our findings indicated that MAC 17 and 28 are promising candidates for future development as therapeutic drugs for inflammatory diseases with an endotoxin etiology. (C) 2018 Elsevier Masson SAS. All rights reserved.
• Synthesis and evaluation of curcumin-related compounds for anticancer activity
  作者：Xingchuan Wei、Zhi-Yun Du、Xi Zheng、Xiao-Xing Cui、Allan H. Conney、Kun Zhang

  DOI：10.1016/j.ejmech.2012.04.005

  日期：2012.7

  Sixty-one curcumin-related compounds were synthesized and evaluated for their anticancer activity toward cultured prostate cancer PC-3 cells, pancreas cancer Panc-1 cells and colon cancer HT-29 cells. Inhibitory effects of these compounds on the growth of PC-3. Panc-1 and HT-29 cells were determined by the MTT assay. Compounds E10, F10, FN1 and FN2 exhibited exceptionally potent inhibitory effects on the growth of cultured PC-3, Panc-1 and HT-29 cells. The IC50 for these compounds was lower than 1 mu M in all three cell lines. E10 was 72-, 46- and 117-fold more active than curcumin for inhibiting the growth of PC-3, Panc-1 and HT-29 cells, respectively. F10 was 69-, 34- and 72-fold more active than curcumin for inhibiting the growth of PC-3, Panc-1 and HT-29 cells, respectively. FN1 and FN2 had about the same inhibitory effect as E10 and F10 toward Panc-1 cells but were less active than E10 and F10 toward PC-3 and HT-29 cells. The active compounds were potent stimulators of apoptosis. The present study indicates that E10, F10, FN1 and FN2 may have useful anticancer activity. (C) 2012 Elsevier Masson SAS. All rights reserved.